Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2014
09/30/2014US8846686 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846684 Arbovirus inhibitors and uses thereof
09/30/2014US8846682 Compound suitable for the treatment of synucleopathies
09/30/2014US8846675 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
09/30/2014US8846672 Imidazopyridines as respiratory syncytial virus antiviral agents
09/30/2014US8846670 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
09/30/2014US8846669 Oxazolidinone derivative and medical composition containing same
09/30/2014US8846668 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846658 Oxazine derivatives and their use in the treatment of neurological disorders
09/30/2014US8846655 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/30/2014US8846654 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
09/30/2014CA2669596C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
09/30/2014CA2664152C Serine hydrolase inhibitors
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014152263A1 Exo olefin-containing nuclear transport modulators and uses thereof
09/25/2014WO2014152135A1 Polymorphs and salts of a compound
09/25/2014WO2014152132A1 N-,c-disubstituted azoles for controlling nematode pests
09/25/2014WO2014151863A1 Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014148493A1 Light-emitting device
09/25/2014WO2014147611A1 Quinolines derivatives as novel anticancer agents
09/25/2014WO2014147586A1 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
09/25/2014WO2014147204A1 Heteroaryl substituted indazoles
09/25/2014WO2014146752A1 Materials for electronic devices
09/25/2014WO2014146553A1 Flavonoid derivatives and use thereof
09/25/2014WO2013082345A9 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
09/25/2014US20140288135 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissues
09/25/2014US20140288106 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
09/25/2014US20140288105 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288100 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
09/25/2014US20140288081 Therapeutic compounds and compositions
09/25/2014US20140288067 Carm1 inhibitors and uses thereof
09/25/2014US20140288065 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/25/2014US20140288044 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781513A1 Benzofuran derivatives
09/24/2014EP2781512A1 Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof
09/24/2014EP2780340A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii
09/24/2014EP2780339A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
09/24/2014EP2780334A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides
09/24/2014EP2780331A1 Pharmaceutically active pyrazine derivatives
09/23/2014US8841450 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841449 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841337 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841332 Fungicidal N-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841327 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
09/23/2014US8841324 Heterocyclic compounds as autotaxin inhibitors
09/23/2014US8841312 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/23/2014US8841306 Antimicrobials
09/23/2014US8841301 Selective NR2B antagonists
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841288 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/23/2014CA2543199C Use of crth2 antagonist compounds in therapy
09/18/2014WO2014145118A1 Resorufin derivatives for treatment of oxidative stress disorders
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014144545A2 Substituted benzoxazoles and methods of use thereof
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014144100A2 Sgc stimulators
09/18/2014WO2014143617A1 Deuterium-enriched tanaproget and processes for its preparation
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142127A1 Phenylxanthene derivative
09/18/2014WO2014141218A1 Novel 1, 2, 4-oxadiazol compounds active against gram-positive pathogens
09/18/2014WO2014141187A1 Pyridine derivatives as rearranged during transfection (ret) kinase inhibitors
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014141171A1 Pyridin-4-yl derivatives
09/18/2014WO2014141153A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014WO2014141104A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014WO2014141065A1 Azetidine amide derivatives as orexin receptor antagonists
09/18/2014WO2014140510A1 Pro-drug compounds
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140279A1 Novel inhibitors
09/18/2014WO2014140076A1 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
09/18/2014WO2014139325A1 Therapeutic compounds and compositions
09/18/2014US20140275549 Method for producing phenyl-substituted heterocyclic derivative
09/18/2014US20140275531 Substituted pyridine and pyrazine compounds as pde4 inhibitors
09/18/2014US20140275529 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
09/18/2014US20140275191 Novel 1,2,4- oxadiazol compounds active against gram-positive pathogens
09/18/2014US20140275185 Novel S-Nitrosoglutathione Reductase Inhibitors
09/18/2014US20140275175 Organic compounds
09/18/2014US20140275133 Mineralocorticoid receptor antagonists
09/18/2014US20140275118 Substituted 2-azabicycles and their use as orexin receptor modulators
09/18/2014US20140275111 Novel compounds as rearranged during transfection (ret) inhibitors
09/18/2014US20140275100 Pyridazine derivatives useful in therapy
09/18/2014US20140275095 Substituted piperidine compounds and their use as orexin receptor modulators
09/18/2014US20140275083 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/18/2014US20140275080 N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
09/18/2014US20140275079 Pyrrole amide inhibitors
09/18/2014US20140275077 Uracil derivatives as axl and c-met kinase inhibitors
09/18/2014US20140275074 Heterocyclic derivative having pgd2 receptor antagonist activity
09/18/2014US20140275061 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/18/2014US20140275059 Dna-pk inhibitors
09/18/2014US20140275058 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/18/2014US20140275041 Oxazole tyrosine kinase inhibitors
09/18/2014US20140275028 1,2,5-substituted benzimidazoles as flap modulators
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 647